Page last updated: 2024-11-02

palmidrol and Obesity, Morbid

palmidrol has been researched along with Obesity, Morbid in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mallipedhi, A1
Prior, SL1
Dunseath, G1
Bracken, RM1
Barry, J1
Caplin, S1
Eyre, N1
Morgan, J1
Baxter, JN1
O'Sullivan, SE1
Sarmad, S1
Barrett, DA1
Bain, SC1
Luzio, SD1
Stephens, JW1

Other Studies

1 other study available for palmidrol and Obesity, Morbid

ArticleYear
Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis.
    Journal of diabetes research, 2015, Volume: 2015

    Topics: Adult; Amides; Arachidonic Acids; Bariatric Surgery; Blood Glucose; Body Mass Index; Endocannabinoid

2015